Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers 21-10-2024, 17:00

Iveco Group announces the results of the Annual General Meeting, the publication of its 2022 Sustainability Report, and the launch of an initial 55 million euro tranche of its share buyback program 14-04-2023, 17:45

Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific Northwest 9-05-2024, 20:00